Flu News and Research

RSS

New data from EMD Serono's multiple sclerosis portfolio to be presented at the 66th AAN Annual Meeting

EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced today that new data from the company's multiple sclerosis (MS) portfolio will be presented at the American Academy of Neurology's 66th Annual Meeting, taking place from April 26 – May 3, in Philadelphia, PA.

26 Apr 2014

Covidien net sales increase 3% to $2.60 billion in second quarter fiscal 2014

Covidien plc today announced financial results for the second quarter of fiscal 2014. Second-quarter net sales of $2.60 billion increased 3% from the $2.53 billion in the second quarter a year ago. Operational sales growth was 4% in the second quarter, as foreign exchange rate movement lowered the quarterly sales growth rate by just over one percentage point.

25 Apr 2014

Novartis to buy Glaxosmithkline's oncology unit

The deal, worth billions, will also see Novartis sell its vaccines unit to Glaxo and partner with Glaxo on their consumer divisions. Novartis also said it will sell its animal health division to Eli Lily.

23 Apr 2014

First Edition: April 22, 2014

Today's early morning highlights from the major news organizations, including marketplace news about the Novartis purchase of GlaxoSmithKline's oncology unit for $14.5 billion.

22 Apr 2014

Hospitals ask officials for easier ACO bonuses

The American Hospital Association is lobbying the CMS Innovation Center to make it easier for accountable care organizations to earn Medicare bonuses and delay potential penalties as the agency looks to expand the initiative (Evans, 4/18).

22 Apr 2014

Study finds ginseng can help prevent, treat influenza and RSV infection

Ginseng can help treat and prevent influenza and respiratory syncytial virus (RSV), a respiratory virus that infects the lungs and breathing passages, according to research findings by a scientist in Georgia State University's new Institute for Biomedical Sciences.

22 Apr 2014

First Edition: April 21, 2014

Today's early morning highlights from the major news organizations, including a GAO report on how the Obama administration raised money from outside groups to promote the health law.

21 Apr 2014

Sneeze and cough generate cloud of invisible gas that propels droplets of infectious material

Each sneeze, cough or burp generates a cloud of invisible gas that propels droplets of infectious material farther than originally thought, and smaller droplets actually travel farther than larger ones. A new study from MIT researchers published in the Journal of Fluid Mechanics says this gas cloud extends the reach of droplets by 5 to 200 times.

16 Apr 2014

Irrational health beliefs associated with lower adherence to prescribed cardiac rehab program, says study

Heart patients with beliefs about health that aren't based on medical evidence are more likely to skip sessions of cardiac rehabilitation, new research suggests.

15 Apr 2014

S. pneumoniae serotypes differ between primary and post-viral disease

Certain capsular serotypes of Streptococcus pneumoniae are particularly likely to cause disease in people who have recently experienced a respiratory viral infection, study findings indicate.

14 Apr 2014

Findings pave way for potential therapy to combat H1N1 flu virus

Flu epidemics cause up to half a million deaths worldwide each year, and emerging strains continually threaten to spread to humans and cause even deadlier pandemics. A study by McGill University professor Maziar Divangahi published by Cell Press on April 10 in the journal Immunity reveals that a drug that inhibits a molecule called prostaglandin E2 (PGE2) increases survival rates in mice infected with a lethal dose of the H1N1 flu virus.

11 Apr 2014

Scientists discover protein potentially good target for influenza A virus

Scientists at The University of Texas at Austin have discovered that a protein produced by the influenza A virus helps it outwit one of our body's natural defense mechanisms. That makes the protein a potentially good target for antiviral drugs directed against the influenza A virus.

11 Apr 2014

Guidance on use of Tamiflu needs to be reviewed in light of most recent evidence

Tamiflu (the antiviral drug oseltamivir) shortens symptoms of influenza by half a day, but there is no good evidence to support claims that it reduces admissions to hospital or complications of influenza.

11 Apr 2014

Rite Aid's fourth quarter revenues increase 2.2% to $6.6 billion

Rite Aid Corporation today reported operating results for its fourth quarter and fiscal year ended March 1, 2014.

10 Apr 2014

Novel prediction model improves patient outcomes after paracetamol-induced acute liver failure

In the UK paracetamol toxicity is the most common cause of ALF and has a high mortality rate. It is estimated that 150 to 200 deaths and 15 to 20 LTs occur as a result of poisoning each year in England and Wales.

10 Apr 2014

PeptiDream develops novel macrocyclic peptide inhibitor for treatment of multiple influenza strains

PeptiDream Inc., a public Tokyo-based biopharmaceutical company ("PeptiDream")( TOKYO:4587) announced today, in collaboration with The Tokyo Metropolitan Institute of Medical Science ("Tokyo Metropolitan Institute") the discovery and development of a novel macrocyclic peptide inhibitor for the treatment of multiple influenza strains.

8 Apr 2014

Walgreens' March sales up 4.5% to $6.43 billion

Walgreens had March sales of $6.43 billion, an increase of 4.5 percent from $6.16 billion for the same month in fiscal 2013.

3 Apr 2014

Managing pregnancy-related complications: an interview with Dr. Mark Zakowski

Pregnancy-related mortality has increased over the last 25 years. Ten years ago the top three pregnancy-related mortality diagnoses were hemorrhage, preeclampsia, and embolism (includes thrombotic and amniotic).

2 Apr 2014

EPFL scientists develop computer tool to identify mutations that make influenza resistant to Tamiflu

Tamiflu is one of the few available treatments for those who come down with the flu. But the virus quickly develops resistance; multiplying at a rate of several generations a day, these tiny pathogens rapidly accumulate genetic mutations. Because of this, they have a good chance of developing counterattacks to the antiviral. How can these infinitesimal variations be identified within the immensity of the virus' genetic code? EPFL researchers have created a computer tool that can shed light on the flu virus' formidable adaptability.

1 Apr 2014

Prevalence of autism among 8-year-olds continues to rise in New Jersey

According to a new report from the Centers for Disease Control and Prevention, the estimated prevalence of autism among 8-year-olds in New Jersey rose in the latest reporting year, 2010, to nearly 22 children per thousand, or approximately one child in 45.

28 Mar 2014

Flu News and Research

New data from EMD Serono's multiple sclerosis portfolio to be presented at the 66th AAN Annual Meeting

Covidien net sales increase 3% to $2.60 billion in second quarter fiscal 2014

Novartis to buy Glaxosmithkline's oncology unit

First Edition: April 22, 2014

Hospitals ask officials for easier ACO bonuses

Study finds ginseng can help prevent, treat influenza and RSV infection

First Edition: April 21, 2014

Sneeze and cough generate cloud of invisible gas that propels droplets of infectious material

Irrational health beliefs associated with lower adherence to prescribed cardiac rehab program, says study

S. pneumoniae serotypes differ between primary and post-viral disease

Findings pave way for potential therapy to combat H1N1 flu virus

Scientists discover protein potentially good target for influenza A virus

Guidance on use of Tamiflu needs to be reviewed in light of most recent evidence

Rite Aid's fourth quarter revenues increase 2.2% to $6.6 billion

Novel prediction model improves patient outcomes after paracetamol-induced acute liver failure

PeptiDream develops novel macrocyclic peptide inhibitor for treatment of multiple influenza strains

Walgreens' March sales up 4.5% to $6.43 billion

Managing pregnancy-related complications: an interview with Dr. Mark Zakowski

EPFL scientists develop computer tool to identify mutations that make influenza resistant to Tamiflu

Prevalence of autism among 8-year-olds continues to rise in New Jersey

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News